NCT00255268View on ClinicalTrials.gov

CMAB vs IMAB in Metastatic Prostate Cancer

PHASE4WithdrawnINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

August 31, 2004

Conditions

Metastatic Prostate Cancer

Interventions

DRUG

Goserelin

DRUG

Bicalutamide

Trial Locations (2)

Unknown

Research Site, Metepec

Research Site, Mexico City

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY